SUPPORT HOTLINE (888) 901-2226
Donate Now

BRIEF TITLE: Dietary Intervention to Improve Bladder Cancer Survivorship

A Pragmatic Dietary Intervention to Improve Bladder Cancer Survivorship


  • Org Study ID: I 661820
  • Secondary ID: NCI-2020-06639,I 661820,R21CA253910
  • NCT ID: NCT04548193
  • NCT Alias:
  • Sponsor: Roswell Park Cancer Institute - Other
  • Source: Roswell Park Cancer Institute

Brief Summary

This phase I trial investigates how well a healthy eating program works in improving outcomes in patients with bladder cancer. The behavioral dietary program consists of educational materials, live phone calls, and interactive voice response phone messages. Participating in the healthy eating program may improve eating habits and/or reduce the risk of bladder cancer from coming back.

Detailed Description


PRIMARY OBJECTIVES:

I. Develop an evidence-based behavioral intervention to increase cruciferous vegetable
intake, with the goal of attaining desirable urinary isothiocyanates (ITC) levels effective
for anti-cancer activities.

II. Conduct a feasibility pilot of our dietary behavioral intervention through a hybrid I
implementation randomized controlled design in 80 non-muscle invasive bladder cancer (NMIBC)
survivors, where the treatment group (n=40) will receive an evidence-based telephone
intervention to increase cruciferous vegetable intake and the control group (n=40) will
receive a general fruit and vegetable intake intervention based on National Cancer Institute
(NCI) guidelines.

SECONDARY OBJECTIVE:

I. To ascertain the level of gene expression changes in urinary exfoliated epithelial cells
(due to the intervention) as a surrogate for intermediate efficacy.

EXPLORATORY OBJECTIVE:

I. Engage the clinical care providers of patients enrolled in our intervention to ascertain
the barriers and facilitators of intervention implementation within clinical practice through
conducting 20 semi-structured interviews.

OUTLINE:

AIM I: Develop an evidence-based behavioral intervention using a systematic process
consisting of information gathering, discussion groups, and mock intervention delivery.

AIM II: Patients are randomized to 1 of 2 arms.

ARM A (HEALTHY EATING PROGRAM A): Patients receive mailed educational materials about the
importance of consuming cruciferae, setting healthier eating goals, and the importance of
keeping track of what they eat. Patients also receive one phone call from study staff to make
sure they understood the educational materials received and 11 interactive voice response
(IVR) phone messages over 6 months.

ARM B (HEALTHY EATING PROGRAM B): Patients receive mailed educational materials about general
fruit and vegetable intake, setting healthier eating goals, and the importance of keeping
track of what they eat. Patients also receive one phone call from study staff to make sure
they understood the educational materials received and 11 IVR phone messages over 6 months.

Overal Status Start Date Phase Study Type
Recruiting August 25, 2020 Phase 1 Interventional

Primary Outcomes:

Primary Outcome 1 - Measure: Urinary isothiocyanates levels

Primary Outcome 1 - Time Frame: 6 months

Primary Outcome 2 - Measure: Cruciferae intake

Primary Outcome 2 - Time Frame: 6 months

Condition:

  • Stage 0a Bladder Cancer AJCC v8
  • Stage 0is Bladder Cancer AJCC v8
  • Stage I Bladder Cancer AJCC v8

Eligibility

Criteria:
Inclusion Criteria:

- CANCER PATIENT: Age 18 years old or older (no upper limit)

- CANCER PATIENT: English speaking

- CANCER PATIENT: Diagnosed with stage Tis, Ta, or T1 bladder cancer

- CANCER PATIENT: Resides in the Western New York catchment area

- CANCER PATIENT: Did not receive a partial or radical cystectomy

- CANCER PATIENT: Does not have a prior cancer diagnosis within 12 months of their
bladder cancer diagnosis

- CANCER PATIENT: Does not have a subsequent more advanced bladder cancer diagnosis

- PHYSICIAN: English speaking

- PHYSICIAN: Physician in a clinic located in the catchment area

- PHYSICIAN: Currently treats bladder cancer patients

Exclusion Criteria:

- CANCER PATIENT: Adults unable to consent

- CANCER PATIENT: Adults unable to complete study measures in English

- CANCER PATIENT: Individuals who are not yet adults (infants, children, teenagers)

- PHYSICIAN: Unable to complete the study measures in English
Show More

Gender: All

Minimum Age: N/A

Maximum Age: N/A

Healthy Volunteers: Accepts Healthy Volunteers

Official Information

Name: Karen Yeary

Role: Principal Investigator

Affiliation: Roswell Park Cancer Institute

Location

Facility Status Contact
Roswell Park Cancer Institute
Buffalo, New York 14263
United States
Recruiting Karen Yeary
716-845-6231
karen.yeary@roswellpark.org